Advisory Bodies

Through its advisory bodies,  Canada’s Drug Agency is able to enlist the support of experts from across the country to inform our work. These bodies also facilitate the exchange of health technology information within Canada.  For enquiries or requests for assistance related to our committees, please contact [email protected].

Committees and working groups that provide strategic advice:

• Appropriate Use Advisory Committee (AUAC) 
• Patient and Community Advisory Committee (PCAC)
• Pharmaceutical Advisory Committee Formulary Working Group for Health Technology Assessments
• Pharmaceutical Advisory Committee
• Pharmaceutical Advisory Committee Formulary Working Group (FWG)
• Provincial Advisory Group (PAG)
• Formulary Management Expert Committee (Interim)
• Device Advisory Committee (DAC)
• Post-Market Drug Evaluation Advisory Committee

Committees that provide expert advice and recommendations:

• Canadian Drug Expert Committee (CDEC)
  • Canadian Plasma-Related Product Expert Committee (CPEC)
• pCODR Expert Review Committee (pERC)
• Health Technology Expert Review Panel (HTERP)